Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? I love innovation and working with incredible minds in the pharmaceutical and life science fields who create amazing new technologies and methods of treatment,” says Groetken.
pharmaphorum
MARCH 19, 2021
The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
pharmaphorum
FEBRUARY 11, 2022
During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. About the author.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
pharmaphorum
MAY 30, 2022
.” The partners stress that this novel approach, paired with the “explosion in availability and accessibility of real-world data and real-world evidence”, as Sun states, creates an opportunity to use this new technique to supplement the evidence traditionally generated from clinical trial control groups. About the author.
Drug Discovery World
FEBRUARY 6, 2024
Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. By making lab automation as easy as using a smartphone, the Flex robot democratises access to automation in life sciences research.”
Expert insights. Personalized for you.
52 
Let's personalize your content